Cargando…
IRay therapy as an adjuvant therapy in newly diagnosed patients with neovascular age-related macular degeneration
OBJECTIVES: To determine the safety and efficacy at 12 months of follow-up after stereotactic radiotherapy in combination therapy with intravitreal ranibizumab injections in treatment naïve patients with neovascular age-related macular degeneration. METHODS: Retrospective data analysis in patients w...
Autores principales: | Brand, Christopher, Arnoldussen, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085287/ https://www.ncbi.nlm.nih.gov/pubmed/29662155 http://dx.doi.org/10.1038/s41433-018-0080-9 |
Ejemplares similares
-
Radiation therapy for neovascular age-related macular degeneration
por: Petrarca, Robert, et al.
Publicado: (2011) -
Pipeline therapies for neovascular age related macular degeneration
por: Arepalli, Sruthi, et al.
Publicado: (2021) -
Treatment of neovascular age-related macular degeneration: Current therapies
por: Augustin, Albert J, et al.
Publicado: (2009) -
Emerging Therapies in Neovascular Age-Related Macular Degeneration in 2020
por: Samanta, Anindya, et al.
Publicado: (2020) -
Aflibercept Treatment Results and Association with Baseline Characteristics in Cases of Newly Diagnosed Neovascular Age-Related Macular Degeneration
por: Kıyat, Pelin, et al.
Publicado: (2021)